Filing Flows › HCW Biologics (HCWB) › R&D spending
HCW Biologics (HCWB) R&D spending by quarter
HCW Biologics' R&D spending was $1.2M in Q2 2026 (second quarter 2026), -4% from Q1 2026. Over the last 6 quarters it ranged from $1.0M (Q4 2024) to $1.4M (Q3 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $1.2M | -4% | -2% |
| Q1 2026 | $1.3M | -6% | — |
| Q4 2025 | $1.3M | -5% | +27% |
| Q3 2025 | $1.4M | +14% | — |
| Q2 2025 | $1.2M | +17% | — |
| Q4 2024 | $1.0M | — | — |
Q2 2026 at a glance
HCW Biologics, Q2 2026: revenue $136K (21× year over year), net loss $5.2M, operating cash flow −$4.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is HCW Biologics' R&D spending?
HCW Biologics' R&D spending was $1.2M in Q2 2026 (second quarter 2026), -4% from Q1 2026.
How has HCW Biologics' R&D spending changed?
Over the last 6 quarters it ranged from $1.0M (Q4 2024) to $1.4M (Q3 2025).